Folding@home
  • Join the Fold
  • COVID-19
  • Science
    • Diseases
    • Project Timeline
    • Papers & Results
    • Dig deeper
  • Support
    • FAQ
    • Folding Support Forum
    • Discord
  • Donate
    • USD via Folding@home Foundation
    • Crypto via Folding@home Foundation
    • DAF via Folding@home Foundation
    • Via Washington University in St. Louis
    • Merchandise store
  • Data
  • Statistics
  • News
  • About
    • Gregory Bowman, PhD
    • The Folding@home Consortium (FAHC)
    • Contact us

Archives

Categories

  • Cancer
    • Breast Cancer
    • Epigenetics
    • Kidney Cancer
    • p53
  • Community
  • FAH achievements
  • FAH network connectivity
  • FAH team members
  • Folding@Home
  • Folding@home Blog
    • Meet the classic paper
  • General
  • Heads up
  • How FAH works
  • Infectious diseases
    • Chagas Disease
    • COVID-19
  • Neurological diseases
    • Alzheimer’s Disease
    • Huntington’s Disease
    • Parkinson’s Disease
  • Papers
  • Science
  • Software development
  • Timeline
  • Uncategorized
  • Web/Tech

Author: Ivy Zhang

Could a new class of antibodies treat COVID-19 in a manner that avoids resistance?

October 21, 2020 by Ivy Zhang

Several antibodies are now in clinical trials to both treat and provide protection against COVID-19. But one of these binds in a completely surprising way, and in a manner that may head off viral resistance. How does it work? We’re trying to find out!

Read more